المؤلفون: Shannon Puhalla, M. Friedlander, Igor Bondarenko, Caroline Nickner, Qin Qin, Steven J. Isakoff, Paul K. Marcom, M. Campone, Erik Jakobsen, Judy Garber, E. Chmielowska, M Palácová, Christine K. Ratajczak, H.S. Han, William J. Gradishar, Melinda L. Telli, Mark E. Robson, Jane Qian, Agnes Jager, Susan M. Domchek, D Citrin, Virginia G. Kaklamani, Yaroslav Shparyk, Stacie Peacock Shepherd, Bella Kaufman, Véronique Diéras

المساهمون: Medical Oncology

المصدر: Annals of Oncology, 29(1), 154-161. Elsevier Ltd.
Han, H S, Diéras, V, Robson, M, Palácová, M, Marcom, P K, Jager, A, Bondarenko, I, Citrin, D, Campone, M, Telli, M L, Domchek, S M, Friedlander, M, Kaufman, B, Garber, J E, Shparyk, Y, Chmielowska, E, Jakobsen, E H, Kaklamani, V, Gradishar, W, Ratajczak, C K, Nickner, C, Qin, Q, Qian, J, Shepherd, S P, Isakoff, S J & Puhalla, S 2018, ' Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer : Randomized phase II study ', Annals of Oncology, vol. 29, no. 1, pp. 154-161 . https://doi.org/10.1093/annonc/mdx505

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, medicine.medical_treatment, Genes, BRCA2, Genes, BRCA1, Phases of clinical research, Placebos, chemistry.chemical_compound, 0302 clinical medicine, Single-Blind Method, Neoplasm Metastasis, PARP inhibitors, Benzimidazoles/administration & dosage, Temozolomide/administration & dosage, Hematology, Middle Aged, Metastatic breast cancer, Chemotherapy regimen, Neoplasm Recurrence, Local/drug therapy, 030220 oncology & carcinogenesis, Female, medicine.drug, Adult, medicine.medical_specialty, Veliparib, 03 medical and health sciences, Young Adult, Breast cancer, Breast Neoplasms/drug therapy, SDG 3 - Good Health and Well-being, Internal medicine, Paclitaxel/administration & dosage, medicine, Temozolomide, Humans, Germ-Line Mutation, Platinum, Aged, Chemotherapy, business.industry, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Carboplatin/administration & dosage, Breast Neoplasms, Male/drug therapy, medicine.disease, Carboplatin, 030104 developmental biology, chemistry, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6245faf8fe340df6bb665b1a1db5b1a
https://pure.eur.nl/en/publications/f335467b-a340-4640-9706-dda834d92443

المصدر: Malmström , A , Łysiak , M , Åkesson , L , Jakobsen , I , Mudaisi , M , Milos , P , Hallbeck , M , Fomichov , V , Broholm , H , Grunnet , K , Poulsen , H S , Bratthäll , C , Strandeus , M , Papagiannopoulou , A , Stenmark-Askmalm , M , Green , H & Söderkvist , P 2020 , ' ABCB1 single-nucleotide variants and survival in patients with glioblastoma treated with radiotherapy concomitant with temozolomide ' , The Pharmacogenomics Journal , vol. 20 , pp. 213-219 .

مصطلحات الفهرس: ATP Binding Cassette Transporter, Subfamily B/genetics, Adult, Aged, Antineoplastic Agents, Alkylating/administration & dosage, Brain Neoplasms/genetics, Chemoradiotherapy/methods, Cohort Studies, Female, Genetic Variation/genetics, Glioblastoma/genetics, Humans, Male, Middle Aged, Pilot Projects, Polymorphism, Single Nucleotide/genetics, Survival Rate/trends, Sweden/epidemiology, Temozolomide/administration & dosage, Treatment Outcome, article

URL: https://curis.ku.dk/portal/da/publications/abcb1-singlenucleotide-variants-and-survival-in-patients-with-glioblastoma-treated-with-radiotherapy-concomitant-with-temozolomide(7399c278-d7d7-484e-bfc3-ceb931ccfb49).html
https://doi.org/10.1038/s41397-019-0107-z